Clinical Trials Browser

Phase 2/3 × Stomach Neoplasms × Trastuzumab × Clear all

NCT05980481 2025-09-29

A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer

Phase 2/3 Active not recruiting

Gastrointestinal

Stomach Neoplasms

NCT04082364 2025-06-08

MAHOGANY

Phase 2/3 Completed

82 enrolled 22 charts

Gastrointestinal

Stomach Neoplasms

NCT02581462 2020-08-11

PETRARCA

Phase 2/3 Completed

Gastrointestinal

Stomach Neoplasms